Valuation: GlaxoSmithKline plc

Market Cap 77.4B 104B 90.57B 84.3B 146B 9,945B 148B 994B 390B 4,951B 391B 383B 16,602B P/E 2026 *
12.9x
P/E 2027 * 11.6x
Enterprise Value 95.16B 128B 111B 104B 180B 12,228B 182B 1,222B 479B 6,088B 481B 471B 20,413B EV / Sales 2026 *
2.8x
EV / Sales 2027 * 2.58x
Free-Float
92.75%
Yield 2026 *
3.6%
Yield 2027 * 3.79%
Manager TitleAgeSince
Chief Executive Officer - 01/01/2026
Director of Finance/CFO 64 01/05/2023
Chief Tech/Sci/R&D Officer - 01/12/2021
Director TitleAgeSince
Director/Board Member - 06/05/2026
Director/Board Member 64 01/01/2018
Chairman 68 01/09/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-0.40% - - 104B
-2.47%-6.82%+45.11%+148.43% 1,024B
-1.15%-4.99%+47.73%+48.08% 618B
-1.70%-4.33%+24.65%+64.91% 443B
+0.68%-1.14%+39.61%+33.36% 349B
-1.66%-3.13%+31.63%+39.79% 297B
-8.96%-10.77%+3.27%+5.50% 264B
-1.37%-7.41%-3.42%-43.67% 209B
-1.42%+0.81%+25.62%+64.41% 208B
-0.04%-0.48%+13.44%+71.98% 162B
Average -1.88%-1.35%+25.29%+48.09% 397.08B
Weighted average by Cap. -2.03%-2.17%+32.88%+70.34%

Financials

2026 *2027 *
Net sales 33.97B 45.73B 39.75B 37B 64.16B 4,366B 65.15B 436B 171B 2,173B 172B 168B 7,288B 35.61B 47.93B 41.66B 38.78B 67.24B 4,575B 68.28B 457B 179B 2,278B 180B 176B 7,638B
Net income 5.91B 7.96B 6.92B 6.44B 11.17B 760B 11.34B 75.94B 29.8B 378B 29.9B 29.25B 1,269B 6.64B 8.93B 7.77B 7.23B 12.53B 853B 12.73B 85.2B 33.44B 425B 33.55B 32.81B 1,423B
Net Debt 17.76B 23.91B 20.79B 19.35B 33.55B 2,283B 34.07B 228B 89.51B 1,136B 89.81B 87.84B 3,811B 14.52B 19.55B 16.99B 15.82B 27.42B 1,866B 27.85B 186B 73.16B 929B 73.41B 71.79B 3,115B
Logo GlaxoSmithKline plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
19.32GBP
Average target price
21.51GBP
Spread / Average Target
+11.38%

Quarterly revenue - Rate of surprise